Genitourinary Radiology: Page 10

Standardized accreditation is key for prostate MRI

By Edna Astbury-Ward, PhD

Quality in imaging is never guaranteed -- that is why working toward European-wide accreditation for prostate MRI is the way forward, expert speakers explained at this morning's ECR Master Class. Benchmarking quality in acquisition and reporting must be set within clear clinical pathways, and it is a vital part of the accreditation process.

March 2, 2019

Ga-68 PSMA-11 PET/MRI improves prostate cancer detection

By Wayne Forrest

VIENNA - PET/MRI with the radiopharmaceutical gallium-68 (Ga-68) prostate-specific membrane antigen-11 (PSMA-11) could become a valuable tool in image-guided biopsy and for detecting significant prostate cancer, researchers reported on Wednesday at ECR 2019.

February 28, 2019

Prostatic artery embolization gains clinical momentum

By Dr. Jamal Al Deen Alkoteesh

Prostate artery embolization has emerged as a highly promising interventional radiology procedure for lower urinary tract symptoms secondary to benign prostatic hypertrophy, Dr. Jamal Al Deen Alkoteesh told Arab Health delegates on the final day of the Total Radiology conference in Dubai, United Arab Emirates.

January 31, 2019

FDG-PET/CT improves bladder cancer staging

By Wayne Forrest

Combining metabolic and morphologic data from FDG-PET/CT scans can significantly improve the detection of lymph node metastasis in patients with muscle-invasive bladder cancer before their surgery, according to a French study published online on 21 January in European Radiology.

January 30, 2019

Curium, Progenics partner on PET agent in Europe

By AuntMinnieEurope.com staff writers

Global nuclear medicine firm Curium has joined Progenics Pharmaceuticals in an exclusive agreement to develop and commercialize Progenics' prostate-specific membrane antigen-targeted small molecule PET/CT imaging agent in Europe.

January 2, 2019

U.K. regulator recommends prostate MRI before biopsy

By Philip Ward

The National Institute for Health and Care Excellence in the U.K. has supported the use of multiparametric MRI as a frontline tool in English hospitals to scan for prostate cancer, but the Royal College of Radiologists has already expressed concerns over the shortage of equipment to cope with the additional examinations.

December 13, 2018

Ga-68 PSMA-11 PET/MRI benefits prostate cancer patients

By AuntMinnieEurope.com staff writers

PET/MRI with the radiopharmaceutical gallium-68 (Ga-68) prostate-specific membrane antigen-11 (PSMA-11) is on par with currently available tools for determining the risk of prostate cancer progression, according to a study published in the December issue of the Journal of Nuclear Medicine.

December 12, 2018

US/MRI fusion software enhances prostate biopsies

By Erik L. Ridley

Software that fuses ultrasound and MRI images for guidance of prostate biopsies can help surgeons find clinically significant prostate cancers that would have otherwise been missed, according to research published on 6 December in European Urology.

December 5, 2018

Intrasense debuts new lung, brain AI apps at RSNA 2018

By AuntMinnieEurope.com staff writers

French advanced visualization firm Intrasense is displaying new artificial intelligence (AI) applications for lung and brain imaging in collaboration with partners 12 Sigma Technologies and Quantib at RSNA 2018.

November 26, 2018

Germans develop certification scheme for prostate MRI

The German Radiological Society's uroradiology and genitourinary diagnostics working group has devised a new certification program for multiparametric MRI of the prostate. In a question-and-answer interview, Prof. Matthias Röthke explains about the rationale behind the scheme.

October 25, 2018

YouTube fails as source of patient information

By Rebekah Moan

YouTube videos are unregulated and very unreliable and inaccurate as a source of patient information, according to a new study of prostate biopsies guided by transrectal ultrasound. Researchers from a top London facility found most videos did not discuss complications or side effects, even though healthcare professionals made many of them.

October 23, 2018

JFR 2018: Must you perform prostate MRI before each biopsy?

By Dr. Olivier Rouvière, PhD

Most experts recommend MRI for patients with a history of systematic negative biopsies and in whom there is still a suspicion of prostate cancer, but the added value remains controversial, Dr. Olivier Rouvière, PhD, told delegates at the French national radiology congress (JFR 2018).

October 15, 2018

Previous Page

Page 10 of 22

Next Page